(Br3) Coronary Other
Payments companies reported to CMS as associated with (Br3) Coronary Other. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (Br3) Coronary Other, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (Br3) Coronary Other
These are the largest totals companies reported as associated with (Br3) Coronary Other. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Steve Kim | Tulsa, OK | Cardiovascular Disease | $1,231.80 |
| Garrett Wong | Sacramento, CA | Cardiovascular Disease | $1,153.48 |
| Persio Lopez Loyo | New York, NY | Interventional Cardiology | $230.76 |
| Alaa Omar | Mccomb, MS | Interventional Cardiology | $224.20 |
| Huazhen Chen | Rochelle Park, NJ | Interventional Cardiology | $220.36 |
| Adrian Nugent | Zachary, LA | Interventional Cardiology | $201.01 |
| Dishang Bhavsar | Bolivar, MO | $201.01 | |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $178.29 |
| Saifuldeen Al Qaisi | Peoria, AZ | Interventional Cardiology | $135.43 |
| Nirav Mehta | Surprise, AZ | Interventional Cardiology | $135.43 |
Prescribed (Br3) Coronary Other?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.